In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  procarbazine hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 to 75
Sponsor: Other
Protocol IDs: CGC05MK1002, NCT00188149

2.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: CDR0000531687, EURONET-PHL-C1, EU-20703, EUDRACT-2006-000995-33, CCLG-HD-2007-10, NCT00433459

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: HD18, NCT00515554

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: HD17, NCT01356680

5.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 60
Sponsor: Other
Protocol IDs: CDR0000354225, UON-SHIELD, EU-20346, NCT00079105

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: P060239, NCT00503594

7.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 30
Sponsor: Other
Protocol IDs: CDR0000593560, CRUK-BRD/07/005, EUDRACT-2007-003080-45, EU-20844, BRD/07/005, 18-30, NCT00666484

8.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: GITIL - HD0607, NCT00795613

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000630501, S0816, U10CA032102, SWOG-S0816, NCT00822120

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 00591, Eudract: 2008-007645-31, NCT00989352

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CALGB-50801, CDR0000669076, NCI-2011-02034, NCT01118026

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000672913, CALGB-50604, NCT01132807

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0910259M, NCT01124240

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000702859, ECOG-E2410, E2410, NCT01390584

15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1114, CDR0000703682, NCI-2011-02678, NCT01399372

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: HIV-HL 2004, NCT01468740

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: Targeted BEACOPP, NCT01569204

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: KNOG-1201, NCT01737346

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-068, NCI-2012-01695, U01CA121947, NCT01775475

20.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 12 to 65
Sponsor: Other
Protocol IDs: CIA-HL-1, NCT01304849
New Search